Stay updated with breaking news from Rob Barrow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mind Medicine(NASDAQ:NASDAQ:MNMD) Q1 2022 Earnings Conference Call May16, 2022, 08:30AM ET Company Participants Rob Barrow - CEO Dan Karlin - Chief Medical Officer Miri Halperin Wernli -...
/PRNewswire/ -- The Benzinga Psychedelics Advisory Council is a collective of the leading minds and voices in the psychedelics space, composed of key thought...
Press release content from PR Newswire. The AP news staff was not involved in its creation.
/PRNewswire/ -- The Benzinga Psychedelics Advisory Council is a collective of the leading minds and voices in the psychedelics space, composed of key thought...
MindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial News provided by Share this article MindMed Finalizes Clinical Development Approach for LSD Targeting Generalized Anxiety Disorder as Initial Indication NEW YORK, May 17, 2021 /PRNewswire/ -- MindMed (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ), a leading clinical stage psychedelic medicine company, announces receipt of Type C Meeting Responses from FDA leading to the finalization of the Company's clinical development approach for Project Lucy by selecting Generalized Anxiety Disorder as an initial indication. Mind...